First Choice Healthcare Solutions, Inc.
First Choice Healthcare Solutions, Inc. (FCHS) Financial Performance & Income Statement Overview
Review First Choice Healthcare Solutions, Inc. (FCHS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
First Choice Healthcare Solutions, Inc. (FCHS) Income Statement & Financial Overview
Explore comprehensive income reports for First Choice Healthcare Solutions, Inc. FCHS, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4033.00 | $19801.00 | -$29955.00 | $3303.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $4033.00 | $19801.00 | -$29955.00 | $3303.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $588489.00 | -$116682.00 | $419998.00 | $482298.00 |
| Operating Expenses | $588489.00 | -$116682.00 | $419998.00 | $482298.00 |
| Total Costs & Expenses | $588489.00 | -$116682.00 | $419998.00 | $482298.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $785896.00 | $883716.00 | $368354.00 | $1.38M |
| Depreciation & Amortization | $5630.00 | $8604.00 | $8601.00 | $8682.00 |
| EBITDA | -$606366.00 | $1.04M | -$440252.00 | -$468763.00 |
| EBITDA Ratio | -$150.35 | $14.70 | -$141.92 | |
| Operating Income | -$584456.00 | $136483.00 | -$449953.00 | -$478995.00 |
| Operating Income Ratio | -$144.92 | $15.02 | -$145.02 | |
| Other Income/Expenses (Net) | -$813436.00 | $12235.00 | -$367254.00 | -$1.38M |
| Income Before Tax | -$1.40M | $148718.00 | -$817207.00 | -$1.86M |
| Income Before Tax Ratio | -$346.61 | $27.28 | -$563.84 | |
| Income Tax Expense | $0.00 | $111950.00 | $0.00 | $0.00 |
| Net Income | -$1.40M | $36768.00 | -$817207.00 | -$1.86M |
| Net Income Ratio | -$346.61 | $27.28 | -$563.84 | |
| EPS | -$0.04 | $0.001 | -$0.03 | -$0.06 |
| Diluted EPS | -$0.04 | $0.001 | -$0.03 | -$0.06 |
| Weighted Avg Shares Outstanding | $32.96M | $32.96M | $32.96M | $32.96M |
| Weighted Avg Shares Outstanding (Diluted) | $32.96M | $32.96M | $32.96M | $32.96M |
The company's financials show resilient growth, with revenue advancing from $3303.00 in Q2 2024 to $4033.00 in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit -$584456.00 last quarter, sustaining a consistent -14492% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$606366.00. Net income dropped to -$1.40M, while earnings per share reached -$0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan